Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 6 Neoplasms 4 Multiple Myeloma 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3 Sarcoma 2 Radiation Injuries 2 Osteosarcoma 2 Melanoma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Head and Neck Neoplasms 2 Cognitive Dysfunction 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thymus Neoplasms 1 Thoracic Neoplasms 1 Testicular Neoplasms 1 Substance-Related Disorders 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1

Interventions

Surveys and Questionnaires 3 pazopanib 2 Sunitinib 2 Sorafenib 2 Bevacizumab 2 Patient Reported Outcome Measures 1 Medical Records 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Financial Stress × Patient Reported Outcome Measures × Clear all

NCT05319925 2023-12-15

FIAT

University Hospital Heidelberg

Financial Stress, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡